Sotera Health, Warburg Pincus, and GTCR in $375 Million Secondary Stock Offering

Cleary Gottlieb represented Sotera Health Company (Sotera Health) and two of its principal shareholders, Warburg Pincus and GTCR, in its approximately $375 million secondary public offering of 25 million shares of common stock.

The offering priced on September 4, 2024, and closed on September 6, 2024. All of the shares of common stock offered were sold by the selling shareholders. Sotera Health did not sell any shares and will not receive any proceeds from the offering. The offering was conducted as a “bought deal” (also known as a “registered block trade”), meaning that the offering was not publicly announced, and the underwriter did not conduct public marketing, prior to execution of an underwriting agreement for the offering.

Citigroup acted as underwriter for the offering.

Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the health care industry.